Prevalence of Extended Spectrum Beta-Lactamase Producing Klebsiella Pneumoniae and Escherichia Coli Among Clinical Isolates in Lautech Teaching Hospital, Ogbomoso, Oyo State, Nigeria
Authors
Department of Medical Laboratory Science, Ladoke Akintola University of Technology (Nigeria)
Department of Medical Laboratory Science, Ladoke Akintola University of Technology (Nigeria)
Oladimeji Boluwatife Christianah
Department of Medical Laboratory Science, Ladoke Akintola University of Technology (Nigeria)
Department of Medical Laboratory Science, Ladoke Akintola University of Technology (Nigeria)
Department of Medical Laboratory Science, Ladoke Akintola University of Technology (Nigeria)
Department of Medical Laboratory Science, Ladoke Akintola University of Technology (Nigeria)
Article Information
DOI: 10.51584/IJRIAS.2026.110200017
Subject Category: Medical Laboratory Science
Volume/Issue: 11/2 | Page No: 188-193
Publication Timeline
Submitted: 2026-02-06
Accepted: 2026-02-12
Published: 2026-02-26
Abstract
Klebsiella pneumoniae and Escherichia coli are major extended-spectrum beta-lactamase producing organism. Extended spectrum beta-lactamases (ESBLs) inactivate newer cephalosporins through hydrolysis, increasing therapeutic failure and antibiotic resistance worldwide. This study aimed to determine the prevalence of ESBL-production in clinical Klebsiella pneumoniae and Escherichia coli isolates. A total of one hundred and four (104) Klebsiella pneumoniae and Escherichia coli isolates from various clinical samples were obtained from Medical Microbiology Laboratories of LAUTECH Teaching Hospital. Isolates collected were recovered on MacConkey agar at 35°C and then identified using standard biochemical tests. They were further screened for antimicrobial susceptibility and resistance by disc diffusion method. Isolates that were resistant to at least two of the third-group cephalosporins such as ceftriaxone, cefotaxime and ceftazidime were confirmed as ESBL producers using Double Disks Synergy Test (DDST). Out of the one hundred and four (104) isolates screened, twenty (20) were confirmed by DDST to be ESBL producers. The prevalence rate of ESBL production in clinical Klebsiella pneumoniae and Escherichia coli isolates were observed to be 19.2%. The study established the prevalence of Extended Spectrum Beta-Lactamase producing Klebsiella pneumoniae and Escherichia coli among clinical isolates in the study area. Therefore, monitoring dissemination and transmissions of ESBL producers are highly recommended for optimum patient care and preventing the spread of multidrug resistant (MDR) pathogens.
Keywords
Extended Spectrum Beta-Lactamase, Double Disks Synergy Test, Antimicrobial Susceptibility
Downloads
References
1. Akinyemi, K. O., Abegunrin, R. O., Iwalokun, B. A., Fakorede, C. O., Makarewicz, O., & Neubauer, H. (2021). The Emergence of Klebsiella pneumoniae with Reduced Susceptibility against Third Generation Cephalosporins and Carbepenems in Lagos Hospitals, Nigeria. Antibiotics, 142. [Google Scholar] [Crossref]
2. Ameshe, A., Engda, T., & Gizachew, M. (2022). Antimicrobial resistance patterns, extended-spectrum beta-lactamase production, and associated risk factors of Klebsiella species among UTI-suspected patients at Bahir Dar City, Northwest Ethopia. International Journal of Microbiology, 175-181. [Google Scholar] [Crossref]
3. Barrios, H., Garza-Ramos, U., Mejia-Miranda, I., Reyna-Flores, F., Sanchez-Perez, A., Mosqueda-Garcia, D., & Siva-Sanchez, J. (2017). ESBL-producing Escherichia coli and Klebsiella pneumoniae: The most prevalent clinical isolates obtained between 2005 and 2012 in Mexico. Journal of Global Antimicrobial Resistance, 10, 243-246. [Google Scholar] [Crossref]
4. Chinedu, A. C., Tochukwu, E. J., Anibueze, E. G., & Nympha, E. O. (2022). Prevalence of ESBL genes in Klebsiella pneumoniae from individauals with community-acquired urinary tract infection in rural communities of Enugu State, Nigeria. GSC Biological and Pharmaceutical Sciences, 19(3), 294-303. [Google Scholar] [Crossref]
5. Ekpunobi, F. N., Mgbedo, U. G., Okeye, L., & Agu, C. (2024). Prevalence of ESBL Genes in Klebsiella pneumoniae from Individuals with Community Acquired Urinary Tract Infections in Lagos State, Nigeria. Preprints.org, 4(3), 109-115. [Google Scholar] [Crossref]
6. Elsayed, A. G., Badr, D. F., El Kheir, N. Y., Zaki, M. E., Mossad, A. E., & Mahmoud, E. M. (2024). Prevalence of extended-spectrum beta-lactamase and molecular detection of blaTEM, blaSHV and blaCTX-M genotypes among gram-negative Bacili isolates fro hospiatl acquired infections in pediatrics,one institutional study. Italain Journal of Pediatrics, 50, 31-42. [Google Scholar] [Crossref]
7. Essack, S. Y., Desta, A. T., Abotsi, R. E., & Agoba, E. E. (2017). Antimicrobail resistance in the WHO African region: current status and roadmap for action. Journal of Public Health, 39(1), 8-13. [Google Scholar] [Crossref]
8. Ezeanya, C. C., Agbakoba, N. R., Ejike, C. E., & Okwelogu, S. I. (2017). Evaluation of chromogenic medium for the detection of ESBL with comparison to double-disk synergy test. British Journal of Medicine & Medical Reasearch, 21(12), 2231-2614. [Google Scholar] [Crossref]
9. Fadeyi, A., Zumuk, C., Raheem, R. A., Nwabuisi, C., & Desalu, O. O. (2018). Prevalence and Antibiotic Susceptibility Pattern of ESBL Producing Klebsiellae Isolated from Clinical Specimens in a Nigerian Tertiary Hospital. Africa Journal of Infectious Diseases, 10(1), 32-37. [Google Scholar] [Crossref]
10. Gbolapo, O., Motunrayo, Y., Olusola, O., Olowe, R. A., & Olowe, O. A. (2023). Genotypic Determination of Extended Spectrum β-Lactamases and Carbapenemase Production in Clinical Isolate of Klebsiella Pneumoniae in Southest Nigeria. Infectious Disease Reports, 15(3), 339-353. [Google Scholar] [Crossref]
11. Gundran, R. S., Cardenio, P. A., Salvador, R. T., Sison, F. B., Benigno, C. C., & Kreausukon, K. (2020). Prevalence, antibiogram and resistance profile of extended-spectrum B-lactamase-producing Escherichia coli isolates frompig farms in Luzon, Philippines. Microbiology Drug Resistance, 26(2), 160-168. [Google Scholar] [Crossref]
12. Husna, A., Rahman, M. M., Badruzzaman, A. T., Sikder, M. H., Islam, M. R., Rahman, M. T., & Alam, J. (2023). Extended-Spectrum β-Lactamase(ESBL): Challenges and Opportunities. Biomedicines, 11(11), 2987. [Google Scholar] [Crossref]
13. Iroha, I. R., Okoye, E., Osigwe, C. A., Moses, I. B., Ejikeukwu, C. P., & Nwakaeze, A. E. (2017). Isolation, phenotypic, characterization and prevalence of ESBL-producing Escherichia coli and Klebsiella species from orthopedic wounds in National Orthopedic Hospital Enugu (NOHE) southeast Nigeria. Journal of Pharmaceutical Care and Health System, 4(4), 2376-2419. [Google Scholar] [Crossref]
14. Maduakor, U. C., Okolie, C. D., Udoh, I. C., & Onyemeiukwe, N. F. (2022). Phenotypi Detection of Extended-spectrum Beta-lactamase-Producing Escherichia coli and Klebsiella pneumoniae Isolated from Hospital and Environmenal Sources in Enugu Metropolis, Nigeria. Journal of Advances in Medicine and Medical Research, 34(14), 68-78. [Google Scholar] [Crossref]
15. Mofolorunsho, K. C., Ocheni, H. O., Aminu, R. F., Omatola, C. A., & Olowonibi, O. O. (2021). Prevalence and antimicrobial susceptibility of extended-spectrum beta-lactamases-producing Escherichia coli and Klebsiella pneumoniae isolated in selected hospitals of Anyigba, Nigeria. African Health Sciences, 21(2), 505-512. [Google Scholar] [Crossref]
16. Mojirayo, D. T., & Adewuyi, O. (2017). Prevalence of Extended-Spectrum Beta Lactamase Production in Clinical Escherichia coli Isolates in Ibadan Metropolis, South-west Nigeria. Nigerian Journal of Pharmaceutical Research, 13(1), 45-52. [Google Scholar] [Crossref]
17. Nkengkana, O. A., Founou, R. C., Founou, L. I., Dimani, B. D., Koudoum, P. L., Zenmtsa, J. R., & Mbossi, A. (2023). Phenotypic and genotypic characterization of multi-drug resistant and extended-spectrum B-lactamases-producing Enterobacterales isolated from clinical samples in western region in Cameroon. BMC Infectious Diseases, 23, 819. [Google Scholar] [Crossref]
18. Nwafia, I. N., Ohanu, M. E., Ebede , S. O., & Ozumba, U. C. (2019). Molecular detection and antibiotic resistance pattern of extended-spectrum beta-lactammase-producing Escherichia coli in a Tertiary Hospital in Enugu, Nigeria. Annals of Clinical Microbiology and Antimicrobials, 18(1), 1-7. [Google Scholar] [Crossref]
19. Ogbolu, O. D., Alli, T. O., Olanipekun, L. B., Ojo, O. I., & Makinde, O. O. (2013). feacal carriage of extended-spectrum beta-lactamase(ESBL)-producing commensal Klebsiella pneumoniae and Escherichia coli from hospital out-patients in Southern Nigeria. academicjournals, 5(3), 97-105. [Google Scholar] [Crossref]
20. Okesola, A., & Oni, A. (2012). Prevalence of Extended Spectrum beta lactamase producing Klebsiella in a tertiary care Hospital in southwest Nigeria. Internaional Journal of Pharmaceutical and Biomedical Sciences, 3(4), 148-151. [Google Scholar] [Crossref]
21. Olayemi, O. T., Oyebanji, A. A., Bashir, M. A., Achancho, A. E., Mih, T. M., Daniel, E. T., & Nghonjuyi, N. (2020). Prevalence and Antimicrobial Susceptibility Pattern of Klebsiella Pneumoniae in Sputum Samples of Patients Attending Aminu Kano Teaching Hospital. Africa Health Science, 1, 7-11. [Google Scholar] [Crossref]
22. Olivia, S. E., & Bernard, E. O. (2024). Prevalence of Extended-Spectrum Beta-lactamases (ESBLs) Producing Escherichia coli and Klebsiella pneumoniae among Hospitalized Patients from Nigeria. FUDMA Journal of Sciences, 5(2), 584-595. [Google Scholar] [Crossref]
23. Olowe, O. A., Oladipo, G. O., Makanjuola, O. A., & Olaitan, J. O. (2012). Prevalence of Extended Spectrum Beta-latamases(ESBLs) carrying genes in klebsiella spp fromclinical samples at Ile-ife, South Western Nigeria. International Journal of Pharmaceutical Medicine and Biological Sciences, 1(2), 129-138. [Google Scholar] [Crossref]
24. Olowo-okere, A., Ibrahim, Y. K., Olayinka, B. O., Ehinmidu, J. O., Mohammed, Y., Nabti, L. Z., & Diene, S. (2020). Phenotypic and genotypic characterization of clinical carbapenem-resistant Enterobacteriaceae isolates from Sokoto, Norhwest Nigeria. New Microbe of New Infection, 37, 234-245. [Google Scholar] [Crossref]